Back

The LDL-C paradigm.

29 August 2017 (12:50 - 13:00)
Organised by:
Congress Presentation Part of: PCSK9 inhibitors: the evidence-based story Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Introduction - PCSK9 inhibitors: the evidence-based story.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
Atherosclerosis regression and low LDL-C.
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Evidence for CV event reduction with lower LDL-C.
Professor C. Packard (Glasgow, GB)
Video
Presentation thumbnail
Panel discussion - PCSK9 inhibitors: the evidence-based story.
Professor K. Ray (London, GB)
Video
Presentation thumbnail
What questions remain unanswered?
Professor K. Ray (London, GB)
Video

Access the full session

Session thumbnail
PCSK9 inhibitors: the evidence-based story

The Event

Event poster

ESC Congress 2017

29 August 2017 12:50 CET
You may be interested in
thumbnail
Congress Presentation
Introduction.
28 August 2022
thumbnail
Congress Presentation
Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients
27 August 2022
thumbnail
Congress Session
Optimising cholesterol levels through dietary interventions: key strategies and evidence
23 June 2023
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources